Product Overview
[Drug Name]
Generic Name: Lumbrokinase Enteric-Coated Tablets
Trade Name: Lumbrokinase Enteric-Coated Tablets 300,000 Units * 24 Tablets
[Main Ingredients]
The main ingredient is an enzyme complex extracted and isolated from the cultivated earthworm Eisenia fetida.
[Properties]
This product is a capsule containing a white powder.
[Indications/Main Functions]
This product is suitable for patients with elevated fibrinogen levels and platelet aggregation in ischemic cerebrovascular disease.
[Specifications]
300,000 units * 24 tablets
[Dosage and Administration]
Oral administration: 2 tablets three times daily, or as directed by a physician. Take half an hour before meals. One course of treatment is 3-4 weeks. Two to three courses of treatment are acceptable, or continued until symptoms improve.
[Adverse Reactions]
Rarely, patients may experience mild headaches, dizziness, constipation, and nausea, which do not require special treatment.
[Contraindications]
This product is contraindicated in patients with allergies. [Drug Interactions]
Drug interactions may occur if used concurrently with other medications. Please consult your physician or pharmacist for details.
[Precautions]
1. This product must be taken before meals.
2. Use with caution in patients with a tendency to bleed.
[Pediatric Use]
Not yet established.
[Elderly Use]
Not yet established.
[Pharmacology and Toxicology]
This product is a fibrinolytic enzyme complex that reduces fibrinogen levels, shortens euglobulin lysis time, increases the activity of tissue-type plasminogen activator (t-PA), and reduces the activity of plasminogen activator inhibitor (PAI). It also reduces whole blood viscosity and plasma viscosity. Animal studies have shown that this product is effective in dissolving pulmonary artery thrombosis in rabbits and inferior vena cava thrombosis in rats.
